Data / Form D filings / Aevumed Inc.
Aevumed Inc.: Form D filings
Aevumed Inc., a biotechnology company in Malvern, PA, filed 4 Form D notices with the SEC in 2025. The latest, on June 12, 2025, reports $3 million sold of a $3 million offering to 36 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 109 GREAT VALLEY PARKWAY, Malvern, PA, 19355
- Phone
- (610) 745-7284
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2065988
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | New notice | $3,000,000 | $3,000,000 | 36 | Dec 21, 2021 | sec.gov | |
| Jun 12, 2025 | New notice | $1,500,000 | $1,500,000 | 21 | Sep 28, 2020 | sec.gov | |
| Jun 12, 2025 | New notice | $264,000 | $264,000 | 10 | Apr 19, 2018 | sec.gov | |
| Jun 12, 2025 | New notice | $305,000 | $305,000 | 10 | Nov 12, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| DAVID FARMER | Director | |
| SAIF KHALIL | Executive Officer, Director | |
| WILLIAM SHOPOFF | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Jun 9, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Aevumed Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.